PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma

NCT03299309 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Medulloblastoma
Recurrent Brain Tumor, Childhood
Malignant Glioma

Interventions

DRUG: PEP-CMV

Sponsor

Daniel Landi

Collaborators

[object Object]
[object Object]